End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
33,250 KRW | -0.60% |
|
+0.30% | -15.18% |
Jul. 10 | Hanmi Pharm Chair to Resign from Management | MT |
May. 16 | Hanmi Science Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Business Summary
Number of employees: 403
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Wholesale
85.8
%
| 989,914 | 94.6 % | 1,070,376 | 85.8 % | +8.13% |
Healthcare
8.9
%
| - | - | 110,938 | 8.9 % | - |
Holding
4.1
%
| 51,745 | 4.9 % | 51,236 | 4.1 % | -0.98% |
Other
1.2
%
| 4,396 | 0.4 % | 15,356 | 1.2 % | +249.33% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
97.1
%
| 1,036,996 | 99.1 % | 1,211,816 | 97.1 % | +16.86% |
China
2.7
%
| 8,741 | 0.8 % | 33,860 | 2.7 % | +287.40% |
Other
0.2
%
| 318 | 0.0 % | 2,230 | 0.2 % | +601.60% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jong-Hoon Lim
CEO | Chief Executive Officer | 47 | Apr. 03 |
Ki-Ho Song
DFI | Director of Finance/CFO | 53 | - |
Young-Sook Song
CHM | Chairman | 76 | - |
Ji-Seon Nam
CMP | Compliance Officer | 40 | 17-06-19 |
Jong-Yoon Lim
BRD | Director/Board Member | 51 | - |
Gyu-Sik Kim
PRN | Corporate Officer/Principal | 57 | - |
Ju-Hyun Lim
PRN | Corporate Officer/Principal | 50 | 20-08-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jong-Yoon Lim
BRD | Director/Board Member | 51 | - |
50 | - | ||
Jong-Hoon Lim
CEO | Chief Executive Officer | 47 | Apr. 03 |
Young-Sook Song
CHM | Chairman | 76 | - |
Yu-Cheol Shin
BRD | Director/Board Member | 59 | 19-03-14 |
Yong-Duk Kim
BRD | Director/Board Member | 67 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 68,391,550 | 25,483,218 ( 37.26 %) | 2,243,234 ( 3.280 %) | 37.26 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
HANMI PHARM. CO., LTD. 41.42% | 5,306,122 | 41.42% | 1,042,721,422 $ |
JVM CO., LTD. 39.19% | 4,738,544 | 39.19% | 97,593,678 $ |
HANMI SCIENCE CO., LTD. 2.87% | 1,960,883 | 2.87% | 44,232,050 $ |
Company contact information
![address Hanmi Science Co., Ltd.(A008930)](https://cdn.zonebourse.com/static/address/6493987.png)
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
-15.18% | 1.63B | |
+25.46% | 45.54B | |
+34.52% | 24.51B | |
+26.46% | 16.48B | |
+21.11% | 14.66B | |
+71.42% | 14.3B | |
-0.05% | 6.79B | |
-11.84% | 6.73B | |
+18.15% | 5.87B | |
-8.87% | 5.73B |
- Stock Market
- Equities
- A008930 Stock
- Company Hanmi Science Co., Ltd.